E-LIB Suche - Ergebnisse für: Janes, Matthew R.

1

An Internally Controlled Quantitative Target Occupancy Assa..:

Hansen, Rasmus ; Firdaus, Sarah J. ; Li, Shuangwei...
Scientific Reports. 8 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

2

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific..:

Janes, Matthew R. ; Zhang, Jingchuan ; Li, Lian-Sheng...
Cell. 172 (2018) 3 - p. 578-589.e17 , 2018

Link: https://doi.org/10.1016/..

3

Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lack..:

Mallya, Sharmila ; Fitch, Briana A. ; Lee, J. Scott...
PLoS ONE. 9 (2014) 2 - p. e88865 , 2014

Link: https://doi.org/10.1371/..

4

Selective Inhibition of Phosphoinositide 3-Kinase p110α Pre..:

So, Lomon ; Yea, Sung Su ; Oak, Jean S....
Journal of Biological Chemistry. 288 (2013) 8 - p. 5718-5731 , 2013

Link: https://doi.org/10.1074/..

5

Targeting of the MNK–eIF4E axis in blast crisis chronic mye..:

Lim, Sharon ; Saw, Tzuen Yih ; Zhang, Min...
Proceedings of the National Academy of Sciences. 110 (2013) 25 - p. , 2013

Link: https://doi.org/10.1073/..

6

Xanthopterin‐induced apoptosis in leukemic cell lines:

Metzger, Robert P ; Janes, Matthew R ; Abadi, Parisa.
The FASEB Journal. 26 (2012) S1 - p. , 2012

Link: https://doi.org/10.1096/..

7

The translational landscape of mTOR signalling steers cance..:

Hsieh, Andrew C. ; Liu, Yi ; Edlind, Merritt P....
Nature. 485 (2012) 7396 - p. 55-61 , 2012

Link: https://doi.org/10.1038/..

8

Next-generation flow cytometry:

Janes, Matthew R ; Rommel, Christian
Nature Biotechnology. 29 (2011) 7 - p. 602-604 , 2011

Link: https://doi.org/10.1038/..

9

B-1 Cell Lymphoma in Mice Lacking the Steroid and Xenobioti..:

Casey, Stephanie C. ; Nelson, Edward L. ; Turco, Gina M....
Molecular Endocrinology. 25 (2011) 6 - p. 933-943 , 2011

Link: https://doi.org/10.1210/..

10

Targeting TOR dependence in cancer:

Janes, Matthew R. ; Fruman, David A.
Oncotarget. 1 (2010) 1 - p. 69-76 , 2010

Link: https://doi.org/10.18632..

11

Tipifarnib as a Precision Therapy for HRAS-Mutant Head and ..:

Gilardi, Mara ; Wang, Zhiyong ; Proietto, Marco...
qt672272m4. , 2020

Link: https://escholarship.org..

12

Tipifarnib as a Precision Therapy for HRAS-Mutant Head and ..:

Gilardi, Mara ; Wang, Zhiyong ; Proietto, Marco...
info:eu-repo/semantics/altIdentifier/pmid/32727882. , 2020

Link: http://hdl.handle.net/10..

13

Abstract IA16: Mechanisms of resistance to mTOR inhibitors ..:

Vo, Thanh-Trang ; Lee, Jong-Hoon Scott ; So, Lomon...
qt56r4b5sj. , 2015

Link: https://escholarship.org..

14

Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lack..:

Mallya, Sharmila ; Fitch, Briana A ; Lee, J. Scott...
qt2x9998t9. , 2014

Link: https://escholarship.org..

15

Efficacy of the investigational mTOR kinase inhibitor MLN01..:

Janes, Matthew R ; Vu, Collin ; Mallya, Sharmila...
qt6wj4c6f6. , 2012

Link: https://escholarship.org..